1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow tominersen: new trials by email Literature Review of tominersen trials Research Report on tominersen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease Tominersen, Placebo - Huntington Disease | Phase 2 | Active not recruiting | Hoffmann-La Roche | 301 | 2023-02-03 | 2026-08-10 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139) RO7234292 (RG6042) - Huntington's Disease | Phase 2 | Completed | Hoffmann-La Roche | 46 | 2018-01-02 | 2022-03-24 |
Canada (2) · Germany (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Austria (1) · Denmark (1) · France (1) · Italy (1) · New Zealand (1) · Poland (1) · Portugal (1) · Spain (1) · Switzerland (1) · United States (1)
2023 (1)